Coronavirus disease 2019 (COVID‐19) is of zoonotic origin and caused by the novel beta coronavirus, severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Rapid diagnosis of SARS-CoV-2 infection will help healthcare professionals to treat patients and control the disease more efficiently and effectively.
Verino® Pro SARS-CoV-2 Ag Rapid Test is is an in vitro immunochromatographic assay for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab, oropharyngeal swab or nasopharyngeal swab specimen.
It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
|Verino PRO SARS-CoV-2 Ag rapid test